Transient loss of KLF2 expression is essential for CD8 effector T cell expansion. [PDF]
Kansas GS.
europepmc +1 more source
KLF2 Promotes Ellagic Acid-Mediated Osteogenic Differentiation of Dental Pulp-Derived Stem Cells via Autophagy and Mitochondrial Regulation. [PDF]
Naidu P +4 more
europepmc +1 more source
AXL is a novel ERK5/KLF4 target in MEK inhibitor-treated melanoma. [PDF]
Paudel R +5 more
europepmc +1 more source
Hypothermic machine perfusion protects DCD graft liver from ischemia‑reperfusion injury by enhancing macrophage efferocytosis via KLF2‑NLRP3 signaling. [PDF]
Deng Q +10 more
europepmc +1 more source
Hydroa Vacciniforme Lymphoproliferative Disorder With a Truncating KLF2 Variant Presenting as Benign Photodermatoses. [PDF]
Warner-Levy J +3 more
europepmc +1 more source
Dual regulation of CXCR6<sup>+</sup>CD8<sup>+</sup> T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression. [PDF]
Xingming Z +12 more
europepmc +1 more source
Targeting lncRNA RP11-358L4.1 attenuates breast cancer cell proliferation and is associated with cell cycle and immune-related transcriptomic signatures. [PDF]
Yangyang Z +11 more
europepmc +1 more source
Modulating <i>Bacteroides</i> to boost anti-PD-1 immunotherapy in HCC. [PDF]
Qi X +8 more
europepmc +1 more source
FOXO1 Integrates Endothelial Hemodynamic, Inflammatory, and Metabolic Pathways in Atherosclerosis. [PDF]
Deng H +5 more
europepmc +1 more source
Targeting CDC42 Protects Mitochondrial Function through KLF2/HIF-1α/PINK1 Signaling in Acute Kidney Injury. [PDF]
Zhou X +13 more
europepmc +1 more source

